| U |
|
U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
|
| Soucie J.M., Miller C.H., Creary M., Hooper W.C., Abshire T.C., Brettler D.B., Bockenstedt P., DiPaola J., Massey G., Neff A., Shapiro A., Tarantino M., Wicklund B.M., DiMichele D., U.D.C. Working Group |
| |
|
U1SNRNP-MEDIATED RESCUE OF MRNA PROCESSING IMPAIRED BY SPLICING MUTATIONS IN SEVERE FACTOR VII DEFICIENCY
|
| Pinotti M., Rizzotto L., Cavallari N., Lewandowska M.A., Chuamsunrit A., Sasanakul W., Mariani G., Pagani F., Bernardi F. |
| |
|
UFH PHARMACOLOGY IN CHILDREN
|
| Newall F., Johnston L., Ignjatovic V., Cranswick N., Lane G., Summerhayes R., Monagle P. |
| |
|
ULTRASTRUCTURAL ANALYSIS OF CULTURED MEGAKARYOCYTES GROWN FROM BONE MARROW MONONUCLEAR CELLS OF A NEWLY DIAGNOSED JAPANESE PATIENT WITH GRAY PLATELET SYNDROME
|
| Yokoyama K., Suzuki H., Matsubara Y., Murata M., Ikeda Y. |
| |
|
UNALTERED CA2+ HOMEOSTASIS AND AGONIST-INDUCED ACTIVATION IN PLATELETS LACKING TRANSIENT RECEPTOR POTENTIAL (TRP) C1
|
| Varga-Szabo D., Braun A., Bender M., Dietrich A., Nieswandt B. |
| |
|
UNEXPECTED FINDING OF RAISED UNDERCARBOXYLATED FII (PIVKA-II) IN FVII DEFICIENCY
|
| Tulpule S., Rangarajan S., Madan B., Cutler J., Shearer M. |
| |
|
UNEXPLAINED HIGH D-DIMER
|
| Pechlaner C., Eller P., Heingärtner C., Hartig F., Falkensammer G., Griesmacher A. |
| |
|
UNEXPLAINED PROLONGED PLATELET FUNCTION ANALYZER (PFA-100) CLOSURE TIME INDUCED BY SAMPLE ANTICOAGULANT
|
| Loreth R.M., Blauth G., Albert F.W. |
| |
|
UNFRACTIONATED HEPARIN (UFH) OR LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AS PERIOPERATIVE BRIDGING THERAPY IN PATIENTS WITH MECHANICAL HEART VALVES (MHVS) ON LONG-TERM ORAL ANTICOAGULANTS (OAC): RESULTS FROM THE REGIMEN REGISTRY
|
| Spyropoulos A.C., Dunn A.S., Turpie A.G.G., Kaatz S., Douketis J., Jacobson A.K., Petersen H. |
| |
|
UNFRACTIONATED HEPARIN (UFH) PHARMACOKINETICS IN CHILDREN
|
| Newall F., Ignjatovic V., Johnston L., Summerhayes R., Cranswick N., Lane G., Monagle P. |
| |
|
UNFRACTIONATED HEPARIN MONITORING IN THE PRESENCE OF THE LONG-ACTING ANTI-XA AGENT IDRAPARINUX (SR34006): EFFECT OF EXOGENOUS ANTITHROMBIN
|
| Gouin-Thibault I., Samama M.M. |
| |
|
UNIQUE RECIPROCAL MAP KINASE REGULATION IN THROMBIN-INDUCED ENDOTHELIAL PRO-INFLAMMATORY ACTIVATION
|
| Salers P., Farnarier C., Bongrand P., Dignat-George F., Kaplanski G. |
| |
|
UNRAVELING THE MECHANISM OF INACTIVATION OF ACTIVATED TAFI
|
| Marx P.F., Mörgelin M., Plug T., Havik S.R., Meijers J.C.M. |
| |
|
UPAR IS AN IMPORTANT MODULATOR OF TUBULAR REPAIR AFTER RENAL ISCHEMIA REPERFUSION INJURY
|
| Roelofs J.J.T.H., Claessen N., Stokman G., Teske G.J.D., Weening J.J., Florquin S. |
| |
|
UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE
|
| Tagariello G., Belvini D., Salviato R., Di Gaetano R., Pietrobon F., Radossi P., Sartori R., Tassinari C., Zanotto D., Bicocchi P., Castaldo G., Margaglione M. |
| |
|
UP-REGULATION OF ACTIVATED PROTEIN-C RECEPTOR ON HUMAN ENDOTHELIAL CELLS BY ALDOSTERONE
|
| Ducros E., Mirshahi S., Soria J., Mirshahi M. |
| |
|
UPREGULATION OF INFLAMMATORY MEDIATORS IN LUNG CANCER AND THEIR MODULATION BY ORAL ANTICOAGULANT THERAPY
|
| Hoppensteadt D., Demir M., Cunanan J., Jeske W., Iqbal O., Bick R., Fareed J. |
| |
|
UPREGULATION OF MICROPARTICLES IN HEPARIN INDUCED THROMBOCYTOPENIA (HIT) AND IT'S MODULATION BY ARGATROBAN
|
| Jeske W.P., Hoppensteadt D., Walenga J.M., Cunanan J., Nelson K., Messmore H.L., Fareed J. |
| |
|
UPREGULATION OF MYELOPEROXIDASE IN END STAGE RENAL DISEASE AND ITS MODULATION BY HEMODIALYSIS
|
| Bansal V., Cunanan J., Hoppensteadt D., Wahi R., Fareed J. |
| |
|
UPREGULATION OF NITRIC OXIDE AND ASYMMETRIC DIMETHYLARGININE LEVELS IN MALIGNANCY ASSOCIATED THROMBOSIS AND THEIR MODULATION BY ANTICOAGULANTS
|
| Hoppensteadt D., Jeske W.P., Fareed D., Iqbal O., Bick R., Fareed J. |
| |
|
UPREGULATION OF SURROGATE MARKERS OF INFLAMMATION AND THROMBOGENESIS IN ESRD PATIENTS, PATHOPHYSIOLOGIC AND THERAPEUTIC IMPLICATIONS
|
| Nelson K., Cunanan J., Hoppensteadt D., Bansal V., Bajwa G., Fareed J. |
| |
|
URINARY EXCRETION OF VITAMIN K METABOLITES IN TERM AND PRETERM INFANTS
|
| Harrington D.J., Clarke P., Mitchell S.J., Voong K., Card D.J., Shearer M.J. |
| |
|
UROKINASE (UPA) INDUCES ENDOTHELIAL CELL SURVIVAL VIA THE X-LINKED INHIBITOR OF APOPTOSIS PROTEIN (XIAP)
|
| Prager G.W., Brunner P., Mihaly J., Binder B.R. |
| |
|
USAGE OF FACTOR VIIA IN A CASE OF HEMORRHAGIC CYSTITIS DEVELOPED SECONDARY TO CHEMOTHERAPY
|
| Akarsu S., Durukan Tosun M., Gurgoze M., Arslan N., Yildirmaz S. |
| |
|
USE OF A CLINICAL ALGORITHM IN THE DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA
|
| McBride E.R., Sadek I., Shawwa A. |
| |
|
USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY
|
| Lee J.M., Dash C.H., Chernova T., Baglin T., Collins P., Serban M., Hay C., Matysiak M., Mitchell V., Plyusch O., Rusen L., Stasyshyn O. |
| |
|
USE OF A HUMAN-DERIVED D-DIMER PREPARATION IN EXTERNAL QUALITY ASSESSMENT (EQA)
|
| Crowther M., Raby A., Keeney M., Flynn G. |
| |
|
USE OF FONDAPARINUX IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA TYPE II
|
| Schindewolf M., Luxembourg B., Lindhoff-Last E. |
| |
|
USE OF HAEMOPHILIA A ZEBRAFISH FOR SENSITIVE SCREENING AND CHARACTERISATION OF NOVEL PLATELET CANDIDATE GENES DERIVED FROM POST-GENOME STUDIES FOR PRO-THROMBOTIC FUNCTION
|
| O'Connor M.N., Salles I.I., Ouwehand W.H., Deckmyn H., Stemple D.L. |
| |
|
USE OF RECOMBINANT ACTIVATED FACTOR VII IN NON-HEMOPHILIC CHILDREN
|
| Sciuccati G.B., Feliú Torres A., Hepner M.D., Pieroni G., Frontroth J.P., Althabe M., Magliola R., Bonduel M.M. |
| |
|
USE OF RECOMBINANT ACTIVATED FACTOR VIIA (RFVIIA) IN MASSIVE HAEMORRHAGE
|
| Westwood J., Arnott S., Patel R., Arya R. |
| |
|
USE OF RECOMBINANT ACTIVETED FACTOR VII FOR THE CONTROL OF POST PARTUM HEMORRHAGE: A CASE SERIES
|
| Shamsi T.S., Hossain N., Farzana T., Haider S., Soomro N., Khan N. |
| |
|
USE OF RECOMBINANT FACTOR VIIA (RFVIIA) IN THE MANAGEMENT OF MAJOR HAEMORRHAGE - A SURVEY OF CURRENT UK PRACTICE
|
| Biss T.T., Hanley J.P. |
| |
|
USE OF RECOMBINANT FACTOR VIIA IN CARDIOSURGERY PATIENTS, INCLUDING NEONATES AND INFANTS UNDER 1 YEAR OF AGE
|
| Samsonova N.N., Bokeria L.A., Lobacheva G., Diasamidze K., Klimovich L.G., Kozar E., Plushch M. |
| |
|
USE OF RFVIIA IN ELECTIVE SURGERY IN CASES WITH CONGENITAL COAGULOPATHIES AND INHIBITORS
|
| Boadas A., Ruiz-Saez A., Fernandez-Palazzi F., Cedeño M., Pachano S., Aguiar A., de Bosch N. |
| |
|
USE OF SOLUBLE FIBRIN MONOMER (SFM) WITH DDIMER (DDI) AND THE ISTH SCORE MAY AID IN DIAGNOSIS OF DIC
|
| Woodhams B.J., Cauchie P., Ollieuz S., Kimbimbi P., Deschepper N., Cauchie C., Brohée D. |
| |
|
USE OF THROMBOELASTOGRAPHY TO DEFINE THE ROLE(S) OF NEUTROPHIL ELASTASE DURING NORMAL HAEMOSTASIS IN VITRO
|
| Ho V., Nesheim M.E., Samis J.A. |
| |
|
USE THROMBIN GENERATION ASSAY AND THROMBELASTOGRAPHY IN MONITORING OF RESPONSE TO DDAVP IN PATIENTS WITH TYPE 1 AND 2A VON WILLEBRAND DISEASE
|
| Hrachovinová I.V., Hladíková M., Habart D., Rittich [Scaron]., Salaj P. |
| |
|
USEFULNESS OF A D-DIMER KIT NEWLY DEVELOPED FOR STANDARDIZATION
|
| Magari Y., Shibata T. |
| |
|
USEFULNESS OF MULTIDETECTOR COMPUTED TOMOGRAPHY IN PATIENTS WITH SYMPTOMS SUGGESTING PULMONARY EMBOLISM
|
| Roy P., Guillemette P., Righini M., Le Gal G., Sanchez O., Gourdier A., Howarth N., Revel M., Perrier A. |
| |
|
USEFULNESS OF PERFUSION LUNG SCAN COMBINED WITH CLINICAL ASSESSMENT TO RULE OUT PULMONARY EMBOLISM
|
| Penaloza A., Blocklet D., Tang B.N.T., Melot C., Motte S. |
| |
|
USING A PROTEOMIC APPROACH TO IDENTIFY SPECIFIC STREPTOCOCCAL PROTEINS RESPONSIBLE FOR INDUCING PLATELET AGGREGATION IN INFECTIVE ENDOCARDITIS
|
| Kerrigan S.W., Keane C., Jacubovics N., Jenkinson H., Cox D. |
| |
